Russell Lesley
SEC-identified person · CIK 1374636 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Enanta Pharmaceuticals INC ENTA | Director | filed 2016 - 2026 |
| Scopus Biopharma Inc. SCPS | Director | filed 2020 - 2020 |
| Endocyte INC ECYT | Director | filed 2013 - 2018 |
| Amag Pharmaceuticals, INC. AVM | Director | filed 2009 - 2018 |
| Innocoll Holdings plc INNL | Chief Medical Officer | filed 2017 - 2017 |
| Tetralogic Pharmaceuticals Corp TLOG | Chief Operating Officer | filed 2013 - 2015 |
| Cephalon INC CEPH | Sr VP, Worldwide Med & Reg Ops | filed 2006 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.